All Stories

  1. Platelet count and risk of severe illness in hospitalised children with Influenza‐Like illness
  2. Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators
  3. The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study
  4. Infant pulmonary function tests in individuals with Down syndrome
  5. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis‐related diabetes
  6. Pediatric admissions due to respiratory diseases during the COVID-19 pandemic
  7. The clinical significance of thrombocytosis in children with viral respiratory tract infections
  8. Variation in the pattern of childhood respiratory viral infections during the COVID-19 pandemic
  9. Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis
  10. Persistent hypoxaemia and a headache in a previously healthy 11-year-old girl
  11. Ethical Dilemma
  12. Infant Pulmonary Function Tests in Individuals with Down Syndrome
  13. Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis
  14. A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis
  15. The Use of Infant Pulmonary Function Tests in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy
  16. Sleep in children with cystic fibrosis: More under the covers
  17. Betamethasone versus dexamethasone for inpatient preschool wheezing—A case‐control study
  18. Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia
  19. Whole Exome Sequencing Accuracy in the Diagnosis of Primary Ciliary Dyskinesia
  20. Reply to Turnbull et al. and to Hulme et al.
  21. Structural determinants of long-term functional outcomes in young children with cystic fibrosis
  22. Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis
  23. Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis
  24. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease
  25. Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study
  26. Predicting disease progression in cystic fibrosis
  27. Side effects of medications used to treat childhood interstitial lung disease
  28. Oropharyngeal swabs not useful in young children with CF
  29. A quality improvement intervention to reduce emergency department radiography for bronchiolitis
  30. Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia
  31. Respiratory Hospitalizations and Rehospitalizations in Infants Born Late Preterm
  32. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis
  33. Food Safety Crisis Management-A Comparison between Germany and the Netherlands
  34. Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease
  35. Treatment of cystic fibrosis in low-income countries
  36. The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia
  37. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy
  38. Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity
  39. Neurological complications and pandemic influenza A (H1N1) virus infection